Catalyst Wire Dossier Catalyst Wire Dossier

Synacthen

tetracosactide
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Synacthen, covering 2014-05-01 to 2025-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE) [Phase 2]

See pricing